Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma

Valerio Gallotta, Marco D'Indinosante, Camilla Nero, Maria Teresa Giudice, Carmine Conte, Claudio Lodoli, Gian Franco Zannoni, Anna Fagotti, Giovanni Scambia

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Study Objective: To demonstrate management of a rare case of an isolated intraparenchymal splenic metastasis of endometrial cancer with robotic-assisted surgery. Design: Case report (Canadian Task Force Classification III). Setting: A 55-year-old patient with a history of endometrial cancer was found to have a splenic lesion on a follow-up examination. She underwent surgical staging, involving total hysterectomy, bilateral salpingo-oopherectomy, pelvic lymphadenectomy, and peritoneal washing, in 2014, and the final pathological findings showed an endometrioid endometrial adenocarcinoma, International Federation of Gynecology and Obstetrics stage IB G2. Multidisciplinary counseling was provided, and the patient opted for strict medical surveillance. At 20 months after the primary treatment, the patient experienced a vaginal cuff recurrence and refused radiation therapy. She instead underwent robotic surgery, followed by 6 cycles of carboplatin 6 AUC and paclitaxel 175 mg/m2. Seventeen months later, a positron emission tomography/computed tomography scan revealed a 3-cm intraparenchymal lesion of the spleen, and robotic splenectomy was scheduled. The Institutional Review Board approved this study. Intervention: The operative time was 90 minutes, and blood loss was <50 mL. The operation was performed successfully, with no intraoperative and postoperative complications. Histopathological analysis showed a 3-cm intraparenchymal splenic lesion. The patient was discharged on day +2, and 46 days later started adjuvant chemotherapy based on carboplatin 6 AUC and doxorubicin (Caelyx) 30 mg/m2. At a 2-month follow-up, the patient was disease-free and in good general condition. Conclusion: This case demonstrates the successful robotic management of recurrent endometrial cancer.

Original languageEnglish
Pages (from-to)774-775
Number of pages2
JournalJournal of Minimally Invasive Gynecology
Volume25
Issue number5
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Robotics
Splenectomy
Adenocarcinoma
Recurrence
Endometrial Neoplasms
Carboplatin
Area Under Curve
Endometrioid Carcinoma
Research Ethics Committees
Intraoperative Complications
Advisory Committees
Adjuvant Chemotherapy
Operative Time
Paclitaxel
Lymph Node Excision
Hysterectomy
Gynecology
Doxorubicin
Obstetrics
Counseling

Keywords

  • Endometrial cancer
  • Endometrial recurrence
  • Robotic surgery
  • Splenectomy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma. / Gallotta, Valerio; D'Indinosante, Marco; Nero, Camilla; Giudice, Maria Teresa; Conte, Carmine; Lodoli, Claudio; Zannoni, Gian Franco; Fagotti, Anna; Scambia, Giovanni.

In: Journal of Minimally Invasive Gynecology, Vol. 25, No. 5, 01.07.2018, p. 774-775.

Research output: Contribution to journalArticle

Gallotta, V, D'Indinosante, M, Nero, C, Giudice, MT, Conte, C, Lodoli, C, Zannoni, GF, Fagotti, A & Scambia, G 2018, 'Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma', Journal of Minimally Invasive Gynecology, vol. 25, no. 5, pp. 774-775. https://doi.org/10.1016/j.jmig.2017.10.034
Gallotta, Valerio ; D'Indinosante, Marco ; Nero, Camilla ; Giudice, Maria Teresa ; Conte, Carmine ; Lodoli, Claudio ; Zannoni, Gian Franco ; Fagotti, Anna ; Scambia, Giovanni. / Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma. In: Journal of Minimally Invasive Gynecology. 2018 ; Vol. 25, No. 5. pp. 774-775.
@article{dd96fabfabb04a8d8add4cb10158a6f3,
title = "Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma",
abstract = "Study Objective: To demonstrate management of a rare case of an isolated intraparenchymal splenic metastasis of endometrial cancer with robotic-assisted surgery. Design: Case report (Canadian Task Force Classification III). Setting: A 55-year-old patient with a history of endometrial cancer was found to have a splenic lesion on a follow-up examination. She underwent surgical staging, involving total hysterectomy, bilateral salpingo-oopherectomy, pelvic lymphadenectomy, and peritoneal washing, in 2014, and the final pathological findings showed an endometrioid endometrial adenocarcinoma, International Federation of Gynecology and Obstetrics stage IB G2. Multidisciplinary counseling was provided, and the patient opted for strict medical surveillance. At 20 months after the primary treatment, the patient experienced a vaginal cuff recurrence and refused radiation therapy. She instead underwent robotic surgery, followed by 6 cycles of carboplatin 6 AUC and paclitaxel 175 mg/m2. Seventeen months later, a positron emission tomography/computed tomography scan revealed a 3-cm intraparenchymal lesion of the spleen, and robotic splenectomy was scheduled. The Institutional Review Board approved this study. Intervention: The operative time was 90 minutes, and blood loss was <50 mL. The operation was performed successfully, with no intraoperative and postoperative complications. Histopathological analysis showed a 3-cm intraparenchymal splenic lesion. The patient was discharged on day +2, and 46 days later started adjuvant chemotherapy based on carboplatin 6 AUC and doxorubicin (Caelyx) 30 mg/m2. At a 2-month follow-up, the patient was disease-free and in good general condition. Conclusion: This case demonstrates the successful robotic management of recurrent endometrial cancer.",
keywords = "Endometrial cancer, Endometrial recurrence, Robotic surgery, Splenectomy",
author = "Valerio Gallotta and Marco D'Indinosante and Camilla Nero and Giudice, {Maria Teresa} and Carmine Conte and Claudio Lodoli and Zannoni, {Gian Franco} and Anna Fagotti and Giovanni Scambia",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.jmig.2017.10.034",
language = "English",
volume = "25",
pages = "774--775",
journal = "Journal of Minimally Invasive Gynecology",
issn = "1553-4650",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma

AU - Gallotta, Valerio

AU - D'Indinosante, Marco

AU - Nero, Camilla

AU - Giudice, Maria Teresa

AU - Conte, Carmine

AU - Lodoli, Claudio

AU - Zannoni, Gian Franco

AU - Fagotti, Anna

AU - Scambia, Giovanni

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Study Objective: To demonstrate management of a rare case of an isolated intraparenchymal splenic metastasis of endometrial cancer with robotic-assisted surgery. Design: Case report (Canadian Task Force Classification III). Setting: A 55-year-old patient with a history of endometrial cancer was found to have a splenic lesion on a follow-up examination. She underwent surgical staging, involving total hysterectomy, bilateral salpingo-oopherectomy, pelvic lymphadenectomy, and peritoneal washing, in 2014, and the final pathological findings showed an endometrioid endometrial adenocarcinoma, International Federation of Gynecology and Obstetrics stage IB G2. Multidisciplinary counseling was provided, and the patient opted for strict medical surveillance. At 20 months after the primary treatment, the patient experienced a vaginal cuff recurrence and refused radiation therapy. She instead underwent robotic surgery, followed by 6 cycles of carboplatin 6 AUC and paclitaxel 175 mg/m2. Seventeen months later, a positron emission tomography/computed tomography scan revealed a 3-cm intraparenchymal lesion of the spleen, and robotic splenectomy was scheduled. The Institutional Review Board approved this study. Intervention: The operative time was 90 minutes, and blood loss was <50 mL. The operation was performed successfully, with no intraoperative and postoperative complications. Histopathological analysis showed a 3-cm intraparenchymal splenic lesion. The patient was discharged on day +2, and 46 days later started adjuvant chemotherapy based on carboplatin 6 AUC and doxorubicin (Caelyx) 30 mg/m2. At a 2-month follow-up, the patient was disease-free and in good general condition. Conclusion: This case demonstrates the successful robotic management of recurrent endometrial cancer.

AB - Study Objective: To demonstrate management of a rare case of an isolated intraparenchymal splenic metastasis of endometrial cancer with robotic-assisted surgery. Design: Case report (Canadian Task Force Classification III). Setting: A 55-year-old patient with a history of endometrial cancer was found to have a splenic lesion on a follow-up examination. She underwent surgical staging, involving total hysterectomy, bilateral salpingo-oopherectomy, pelvic lymphadenectomy, and peritoneal washing, in 2014, and the final pathological findings showed an endometrioid endometrial adenocarcinoma, International Federation of Gynecology and Obstetrics stage IB G2. Multidisciplinary counseling was provided, and the patient opted for strict medical surveillance. At 20 months after the primary treatment, the patient experienced a vaginal cuff recurrence and refused radiation therapy. She instead underwent robotic surgery, followed by 6 cycles of carboplatin 6 AUC and paclitaxel 175 mg/m2. Seventeen months later, a positron emission tomography/computed tomography scan revealed a 3-cm intraparenchymal lesion of the spleen, and robotic splenectomy was scheduled. The Institutional Review Board approved this study. Intervention: The operative time was 90 minutes, and blood loss was <50 mL. The operation was performed successfully, with no intraoperative and postoperative complications. Histopathological analysis showed a 3-cm intraparenchymal splenic lesion. The patient was discharged on day +2, and 46 days later started adjuvant chemotherapy based on carboplatin 6 AUC and doxorubicin (Caelyx) 30 mg/m2. At a 2-month follow-up, the patient was disease-free and in good general condition. Conclusion: This case demonstrates the successful robotic management of recurrent endometrial cancer.

KW - Endometrial cancer

KW - Endometrial recurrence

KW - Robotic surgery

KW - Splenectomy

UR - http://www.scopus.com/inward/record.url?scp=85036631530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036631530&partnerID=8YFLogxK

U2 - 10.1016/j.jmig.2017.10.034

DO - 10.1016/j.jmig.2017.10.034

M3 - Article

AN - SCOPUS:85036631530

VL - 25

SP - 774

EP - 775

JO - Journal of Minimally Invasive Gynecology

JF - Journal of Minimally Invasive Gynecology

SN - 1553-4650

IS - 5

ER -